Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Search results for

There are 973 results that match your search.973 results
  • Controversy surrounds two of the most important jobs in IP. That threatens the future stability and development of the IP system, and has an impact on everyone
  • The combined December/January issue of Managing IP is now live on the website, and it’s a good opportunity to highlight some items that are freely available to all readers
  • Filings at the EPO 2012 – top five countries The world might be reeling from recession but it seems as if companies are innovating – or at least patenting – their way out of it. Filings at the EPO were up 5.7% last year, with China recording growth of 11.3%, according to provisional figures. Only one country in the list of top 10 national filers saw a decline in its number of filings: applications from Italy were down 4%.
  • The UK has edged ahead of Germany to rank as the number one IP regime in the world in the fourth edition of the Global IP Index, compiled by law firm Taylor Wessing
  • The 2014 edition of the Global Innovation Index (GII) finds a relatively stable top table, while several developing and middle-income markets make big moves
  • Patent applicants who want to pay for searches for prior art, novelty, invalidity, infringement and freedom to operate will no longer be able to hire the services of European Patent Office officials from the beginning of September.
  • A high-profile patent infringement case is pending before the Delhi High Court. The suit has gained much media attention because it could formulate new rules for the subject matter inquiry under the amended Section 3(d) of the Patents Act, 1970 (IPA). The battle between Roche, a Swiss pharmaceutical company, and Cipla, one of India's biggest drugs companies, relates to the patent of an anti-lung cancer drug.
  • o China:
  • BRAZIL: From March 6, the Brazilian agency responsible for the registration of domain names (FAPESP) will allow registration by foreign companies. Before that date, registration could only be made by local companies.
  • Senior officials from seven IP offices debated the pros and cons of managing all national IP rights under one roof
47
of
98